Aliment Pharmacol Ther

1. OKABAYASHI S, Kobayashi T
   Editorial: Exploring the influence of diet on later-onset ulcerative colitis-Are eggs and spicy foods the key factors in Asia?
   Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.17983.
   

   >> Share

   
   
2. URQUHART SA, Fletcher JG, Bruining DH
   Editorial: Foretelling the future-Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease.
   Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.17991.
   

   >> Share

   
   
3. VUIJK SA, Jongsma MME, Hoeven BM, Cozijnsen MA, et al
   Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's disease.
   Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.18000.
   

   >> Share

   
   
4. FERNANDEZ-CLOTET A, Ordas I, Masamunt MC, Caballol B, et al
   Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease.
   Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.17968.
   

   >> Share

   
   
5. YIU TH, Ko Y, Pudipeddi A, Natale P, et al
   Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease.
   Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18006.
   

   >> Share

   
   
6. FUKUDA T, Yamazaki H, Miyatani Y, Sawada T, et al
   Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
   Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013.
   

   >> Share

   
   
7. SHAH A, Holtmann G
   Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis-associated inflammatory bowel disease?
   Aliment Pharmacol Ther. 2024;59:1290-1291.
   

   >> Share

   
   
8. DERIKX LAAP, Hoentjen F
   Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision?
   Aliment Pharmacol Ther. 2024;59:1296-1297.
   

   >> Share

   
   
9. GARCIA MJ, Gisbert JP, Chaparro M
   Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision? Authors' reply.
   Aliment Pharmacol Ther. 2024;59:1298-1299.
   

   >> Share

   
   
10. SONG S, Wu Z, Lv J, Yu C, et al
    Dietary factors and patterns in relation to risk of later-onset ulcerative colitis in Chinese: A prospective study of 0.5 million people.
    Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.17963.
    

    >> Share

    
    

    
    Am J Gastroenterol

11. STIDHAM RW, Enchakalody B, Wang SC, Su GL, et al
    Artificial Intelligence for Quantifying Cumulative Small Bowel Disease Severity on CT-Enterography in Crohn's Disease.
    Am J Gastroenterol. 2024 Apr 25. doi: 10.14309/ajg.0000000000002828.
    

    >> Share

    
    

    
    Am J Surg

12. CLEMENT E, Lin W, Shojaei D, Au-Yeung P, et al
    Modified 2-stage IPAA has similar postoperative complication rates and functional outcomes compared to 3-stage IPAA.
    Am J Surg. 2024;231:96-99.
    

    >> Share

    
    

    
    Clin Exp Immunol

13. ESLAMIAN G, Jamee M, Momen T, Rohani P, et al
    Genomic Testing Identifies Monogenic Causes in Patients with Very Early-Onset Inflammatory Bowel Disease: A Multi-center Survey in an Iranian Cohort.
    Clin Exp Immunol. 2024 Apr 23:uxae037. doi: 10.1093.
    

    >> Share

    
    
14. PREUSS B, Frank A, Terjung B, Spengler U, et al
    Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Clin Exp Immunol. 2024;216:146-158.
    

    >> Share

    
    
15. MAO Z, Betti MJ, Cedeno MA, Pedroza LA, et al
    Clinical and cellular phenotypes resulting from a founder mutation in IL10RB.
    Clin Exp Immunol. 2024;216:113-119.
    

    >> Share

    
    

    
    Clin Gastroenterol Hepatol

16. SINGH S, Velayos FS, Rubin DT
    Common Instances of Low-value Care in Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2024;22:923-932.
    

    >> Share

    
    
17. SOFIA MA, Feuerstein JD, Narramore L, Chachu KA, et al
    White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States-Removing Barriers and Embracing Opportunities.
    Clin Gastroenterol Hepatol. 2024;22:944-955.
    

    >> Share

    
    

    
    Dis Colon Rectum

18. YILMAZ S, Gunter RL, Kanters AE, Rosen DR, et al
    Segmental Colectomy in Ulcerative Colitis.
    Dis Colon Rectum. 2024 Apr 23. doi: 10.1097/DCR.0000000000003311.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

19. YUAN B, Huang P, Yang M, Tang G, et al
    Intestinal ultrasound scan predicts corticosteroid failure and colectomy risk in patients with ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2024 Apr 17. doi: 10.1097/MEG.0000000000002780.
    

    >> Share

    
    

    
    Gastroenterology

20. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
    Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
    Gastroenterology. 2024;166:826-841.
    

    >> Share

    
    
21. LUJAN R, Buchuk R, Focht G, Yogev D, et al
    Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
    Gastroenterology. 2024;166:815-825.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

22. KHANNA R, Feagan BG, Zou G, Stitt LW, et al
    Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease.
    Inflamm Bowel Dis. 2024 Apr 25:izae089. doi: 10.1093.
    

    >> Share

    
    
23. CHIN S, Fox L, Majumdar A, Oliver M, et al
    Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report.
    Inflamm Bowel Dis. 2024 Apr 24:izae091. doi: 10.1093.
    

    >> Share

    
    
24. FUKUDA T, Aoki Y, Kiyohara H, Yokoyama A, et al
    Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
    Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093.
    

    >> Share

    
    
25. KRUIS W, Bokemeyer B, Jessen P, Hoesl M, et al
    Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study.
    Inflamm Bowel Dis. 2024 Apr 22:izae086. doi: 10.1093.
    

    >> Share

    
    
26. DESAI A, Khataniar H, Hashash JG, Farraye FA, et al
    Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity.
    Inflamm Bowel Dis. 2024 Apr 20:izae090. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

27. CHETWOOD JD, Tran Y, Subramanian S, Smith PJ, et al
    Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2024 Apr 24:jjae059. doi: 10.1093.
    

    >> Share

    
    
28. OLLECH JE, Yanai H
    Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE Study.
    J Crohns Colitis. 2024 Apr 20:jjae054. doi: 10.1093.
    

    >> Share

    
    
29. SCHROEDER MK, Abushamma S, George AT, Ravella B, et al
    TOpCLASS Expert Consensus Classification of Perianal Fistulizing Crohn's Disease: A Real-World Application in a Serial Fistula MRI Cohort.
    J Crohns Colitis. 2024 Apr 20:jjae056. doi: 10.1093.
    

    >> Share

    
    
30. VIEUJEAN S, Lindsay JO, D'Amico F, Ahuja V, et al
    Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD.
    J Crohns Colitis. 2024;18:548-559.
    

    >> Share

    
    
31. HINDMARCH DC, Malashanka S, Shows DM, Clarke AS, et al
    Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2024;18:628-637.
    

    >> Share

    
    

    
    PLoS One

32. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    

    >> Share

    
    
33. ALAHDAL H, Almuneef G, Alkhulaifi MM, Aldibasi O, et al
    Gut microbiota composition in patients with Crohn's disease in Saudi Arabia.
    PLoS One. 2024;19:e0299749.
    

    >> Share

    
    

    
    Scand J Gastroenterol

34. HAMMOUDI N, Hassid D, Bonnet J, Tran Minh ML, et al
    Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.
    Scand J Gastroenterol. 2024;59:553-560.
    

    >> Share

    
    

    
    Z Gastroenterol

35. STRATMANN K, Hentschel V, Zeuzem S, Blumenstein I, et al
    [Iron supplementation in patients with chronic inflammatory bowel disease: recommendations for a practical approach].
    Z Gastroenterol. 2024 Apr 24. doi: 10.1055/a-2274-1610.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share